Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02903394 · ClinicalTrials.gov registry record · NA
Coherence Imaging of the Cervical Epithelium
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02903394 is a NA study that has completed, run by Duke University. The registered enrollment target is 55 participants.
The verdict
NCT02903394, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a multiplexed low coherence interferometry (mLCI) endoscopic probe for mapping the epithelial types of the cervix. This vaginal mLCI probe will obtain optical measurements from the cervix. These measurements can be used to create a map of the surface cells that distinguishes ectocervical epithelia, endocervical epithelia, and the squamocolumnar junction (t-zone), which is the region where cervical dysplasia is most likely to occur.
Interventions
- DEVICE mLCI Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2016-10-27 |
| Est. Completion | 2017-10-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02903394
The ClinicalTrials.gov registry entry for NCT02903394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mLCI Device is the first listed.
NCT02903394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02903394 about?
NCT02903394 is a clinical study titled "Coherence Imaging of the Cervical Epithelium". The purpose of this study is to develop a multiplexed low coherence interferometry (mLCI) endoscopic probe for mapping the epithelial types of the cervix. This vaginal mLCI probe will obtain optical measurements from the cervix. These measurements can be used to create a map of the surface cells tha...
What is the current status of trial NCT02903394?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2016-10-27. Estimated completion is 2017-10-24.
What interventions are being tested in trial NCT02903394?
The interventions under investigation include: mLCI Device (DEVICE).
Who is sponsoring clinical trial NCT02903394?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.